| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRANSPROCEED.2011.08.096 |
| P698 | PubMed publication ID | 22172824 |
| P2093 | author name string | I Roberti | |
| S Vyas | |||
| P2860 | cites work | Noninvasive methods to assess the risk of kidney transplant rejection | Q37693693 |
| Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients | Q40080624 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| The impact of intercurrent EBV infection on ATP levels in CD4+ T cells of pediatric kidney transplant recipients | Q40404573 | ||
| Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy | Q43296097 | ||
| Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management | Q44412715 | ||
| Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: a NAPRTCS report | Q79651869 | ||
| Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay | Q80252200 | ||
| Establishing pediatric immune response zones using the Cylex ImmuKnow assay | Q81543160 | ||
| Mortality in pediatric renal transplantation: a study of the French pediatric kidney database | Q84429852 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 3675-3678 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | Transplantation Proceedings | Q7834825 |
| P1476 | title | Lymphocyte ATP immune cell function assay in pediatric renal transplants: is it useful? | |
| P478 | volume | 43 |
| Q37225333 | Biomarkers for renal transplantation: where are we? |
| Q36562042 | In vivo regeneration of renal vessels post whole decellularized kidneys transplantation |
| Q38165746 | Purinergic signalling in the liver in health and disease |
| Q36546582 | The effective bioengineering method of implantation decellularized renal extracellular matrix scaffolds |
Search more.